ArticleOncoTargets and therapy2022

Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma.

Weitao Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.